Sex/gender effects of glial reactivity on preclinical Alzheimer’s disease pathology - Vila-Castelar, Clara; Akinci, Muge; Palpatzis, Eleni; Aguilar-Dominguez, Pablo; Operto, Gregory; Kollmorgen, Gwendlyn; Quijano-Rubio, Clara; Blennow, Kaj; Zetterberg, Henrik; Falcon, Carles; Fauria, Karine; Gispert, Juan Domingo; et al. (Molecular psychiatry, 2025)
Keywords: 101/1; 59/57; 692/53/2421; 692/699; 82/47; 82/51; Aged; Aged, 80 and over; Alzheimer Disease - cerebrospinal fluid; Alzheimer Disease - metabolism; Alzheimer Disease - pathology; Alzheimer's disease; Amyloid beta-Peptides - cerebrospinal fluid; Amyloid beta-Peptides - metabolism; Behavioral Sciences; Biological Psychology; Biomarkers - cerebrospinal fluid; Cerebrospinal fluid; Chitinase-3-Like Protein 1 - cerebrospinal fluid; Clinical trials; Cohort Studies; Female; Gender; Gender differences; Glial fibrillary acidic protein; Glial Fibrillary Acidic Protein - cerebrospinal fluid; Hippocampus; Hippocampus - metabolism; Hippocampus - pathology; Humans; Magnetic resonance imaging; Magnetic Resonance Imaging - methods; Male; Medicine; Medicine & Public Health; Membrane Glycoproteins - cerebrospinal fluid; Middle Aged; Neurodegenerative diseases; Neuroglia - metabolism; Neuronal-glial interactions; Neurosciences; Pathology; Peptide Fragments - cerebrospinal fluid; Pharmacotherapy; Positron emission tomography; Positron-Emission Tomography - methods; Psychiatry; Psykiatri; Receptors, Immunologic; Regression analysis; Sex Characteristics; Sex differences; Sex Factors; Tau protein; tau Proteins - cerebrospinal fluid; tau Proteins - metabolism